Ying Lin

6PUBLICATIONS
13CO-AUTHORS
Molecular targetsMechanobiologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 11, 2026
Bevacizumab plus nab-paclitaxel and platinum as second-line therapy for driver-gene-negative non-squamous non-small cell lung cancer after immunochemotherapy: A prospective single-arm single-centre study.

|Mar 16, 2026
B3GNT3 facilitates NFKB2 processing and non-canonical NF-κB activation to drive lung adenocarcinoma progression.

Ying Lin, Yao Zhang, Bo Yu

|Mar 11, 2026
Maintenance therapy for metastatic non-squamous non-small cell lung cancer: efficacy and biomarker analysis of pemetrexed discontinuation.

Ying Lin, Ke Gong, Jingjing Wu

|Nov 27, 2025
TAF1 acetyltransferase promotes colorectal carcinoma metastasis by catalyzing β-hydroxybutyrylation of KCTD9.

Jun Su, Miao Zhao, Wanjing Feng

|Apr 04, 2023
Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer.

Jiatao Liao, Hongyan Lai, Chang Liu

|Jan 12, 2018
Protocadherin-8 promotes invasion and metastasis via laminin subunit γ2 in gastric cancer.

Ying Lin, Xiaoxiao Ge, Xiaofei Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Jialei Wang

2 joint publications

Bo Yu

2 joint publications

Huijie Wang

1 joint publications

Jin Li